Since currently it is certainly mandatory to look for the status of 9 genes (EGFR, BRAF, ALK, ROS1, MET, RET, HER2, KRAS, and NTRK) in NS-NSCLC, it would also be possible to use a small NGS panel. This evidence concerns the gene KRAS and non-small cell lung carcinoma.